Cyclerion Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $875 | $93 | $81 | $1,806 |
Gross Profit | 93 | 81 | 1,806 | |
EBITDA | -976 | -1,672 | -1,457 | 502 |
EBIT | -1,672 | -1,457 | 502 | |
Net Income | -976 | -324 | -1,429 | 530 |
Net Change In Cash | 875 | 93 | 81 | 1,806 |
Free Cash Flow | -264 | -503 | -968 | 360 |
Cash | 4,568 | 3,006 | 3,639 | 3,232 |
Basic Shares | 3,225 | 3,071 | 2,556 | 2,545 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,000 | $0 | $297 | $3,320 |
Gross Profit | 2,000 | -5,282 | 3,320 | |
EBITDA | -3,628 | -9,582 | -18,475 | -53,842 |
EBIT | -3,628 | -9,647 | -18,540 | -54,314 |
Net Income | -3,057 | -5,263 | -44,078 | -51,647 |
Net Change In Cash | 2,000 | 0 | 297 | 3,320 |
Free Cash Flow | -4,333 | -21,245 | -40,611 | -36,524 |
Cash | 3,232 | 7,571 | 13,382 | 53,961 |
Basic Shares | 2,518 | 2,338 | 2,173 | 1,957 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.11 |
2025-03-31 | -$0.55 |
2024-12-31 | $0.20 |
2024-09-30 | -$0.28 |
